TRANSIENT arrhythmias are frequently encountered during catheterization of the right side of the heart. 1 They occur most frequently during manipulation of the catheter in the atrium as isolated ...

Oct. 9, 2002 — Defibrillation in unwitnessed cardiac arrest may be harmful, based on the results of an animal study presented on Oct. 8 at the American College of Emergency Physicians Scientific ...

Researchers used an electrophysiological computer model of the heart's electrical circuits to examine the effect of the applied voltage field in multiple fibrillation-defibrillation scenarios. They ...

Vanderbilt University researchers believe a slow electrochemical wave, known as a damped wave, may be one of the reasons that low-voltage defibrillation shocks fail to halt fibrillation in cardiac ...

Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.

Objective: This study was designed to test defibrillation threshold (DFT) with the least number of fibrillation inductions using upper limit of vulnerability (ULV) and to describe the most practical ...

In a paper published this week in Chaos, by AIP Publishing, researchers from Sergio Arboleda University in Bogotá, Colombia, and the Georgia Institute of Technology in Atlanta used an ...

MINNEAPOLIS--(BUSINESS WIRE)--Cardialen, Inc., has published a first-in-human study in the Journal of the American College of Cardiology: Clinical Electrophysiology titled Novel Low-Voltage MultiPulse ...

The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.

MINNEAPOLIS--(BUSINESS WIRE)--Cardialen, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin a clinical trial of its ...